(Reuters) - Global spending on prescription medicines will reach nearly $1.5 trillion by 2021, although the annual rate of growth will decrease from recent years, according to a forecast by Quintiles IMS Holding released on Tuesday.
PARIS (Reuters) - France widened "high risk" restrictions to the entire country after the detection of several cases of the highly pathogenic H5N8 avian flu strain in farms in southwest France and in wild ducks in northern France, the farm ministry said on Tuesday.
SEOUL (Reuters) - South Korea plans to cull more chickens and ducks as it tries to contain an outbreak of bird flu, with a total of around 8 percent of the nation's poultry population expected to be slaughtered.
WASHINGTON (Reuters) - A federal appeals court on Monday brought to an end President Barack Obama's bid to overturn a ruling that threatens to gut his signature healthcare law by putting the case on hold until after President-elect Donald Trump, who aims to repeal Obamacare, takes office.
LONDON (Reuters) - AstraZeneca's pill Tagrisso cut the risk of lung cancer progressing by 70 percent compared to standard chemotherapy in a major clinical trial, lifting prospects for a drug that is key to the company's lofty long-term sales goals.
HONG KONG (Thomson Reuters Foundation) - Even as malnutrition killed millions of children worldwide last year - with many deaths in Asia-Pacific, the region's progress toward defeating hunger has slowed down, a new study has found.
WASHINGTON (Reuters) - A U.S. Justice Department attorney told a federal judge on Monday that health insurer Aetna Inc's planned acquisition of Humana Inc would break antitrust law by reducing competition in Medicare Advantage and Obamacare exchange businesses, kicking off a trial expected to last weeks.
(Reuters) - Pfizer Inc said on Monday its cancer drug, Bosulif, was found superior to Novartis AG's Gleevec in a late-stage study on untreated patients with a form of blood and bone marrow cancer characterized by abnormal white blood cells production.
